Improving biocontainment capabilities for infectious disease research
Official title: Resources and Workforce Development for the Tulane Regional Biocontainment Laboratory
Funded at Tulane University of Louisiana · NIH-10912064 · Data updated 2026-11-12
This study is working to improve a special lab that helps scientists learn more about serious diseases like COVID-19, so they can quickly find better treatments and vaccines that could help people in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | August 22, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $2,842,544 |
| NIH project number | 5UC7AI180314-02 |
| Project ID | NIH-10912064 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals affected by or at risk for emerging infectious diseases, particularly those related to COVID-19.
✕Less likely to help
Patients with non-infectious diseases or those not impacted by emerging infectious diseases may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the capabilities of the Tulane Regional Biocontainment Laboratory (RBL) to study high-consequence pathogens, particularly in the context of emerging infectious diseases like COVID-19. By fortifying the infrastructure and resources available at the laboratory, the project aims to ensure a rapid and effective response to public health threats. The research involves strategic planning and development to support in vivo studies using nonhuman primates, which are critical for understanding and combating infectious diseases. Patients may benefit indirectly through advancements in treatments and vaccines developed from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for infectious diseases affecting human health.
How similar studies have gone: Other research initiatives focused on enhancing biocontainment and infectious disease response have shown promise, particularly during the COVID-19 pandemic, indicating a potential for success in this area.
Where this research is happening
-
Tulane University of Louisiana
New Orleans, United States Active
Researchers
- Principal investigator: Rappaport, Jay — Tulane University of Louisiana
- Study coordinator: Rappaport, Jay
Related research
Other NIH-funded projects on the same topics.
-
Center for Youth Equity: A Community Path to Prevent Youth Violence
A Tulane-led effort partners with communities to reduce youth violence by addressing racism, strengthening local youth voices, and building sustainable prevention strategies.
-
Breeding colony expansion to support HIV/AIDS research with rhesus macaques
A funding opportunity to expand a specialized Rhesus macaque breeding population to support HIV/AIDS research at Tulane’s primate facility.
-
HIV Resilience Observatory in a rhesus macaque colony expansion
A program to build a rhesus macaque breeding colony and use AI-powered monitoring to study why some HIV/AIDS outcomes differ among individuals with similar backgrounds.
-
Indoor-Outdoor Housing Expansion to Support HIV/AIDS-Related Research
A HIV-focused project at a primate research center will use new indoor/outdoor housing and AI-assisted monitoring to study why people with similar backgrounds can have very different HIV outcomes.
-
Whole-body and organ aging clocks from blood proteomics during calorie restriction
This project follows people in long-term calorie restriction studies to see how blood proteins reflect aging across the whole body and specific organs.
-
Unlocking new vaccine ideas by studying ETEC biofilms
A medical research project at Tulane aims to learn how ETEC bacteria form biofilms and how this could lead to a better vaccine for children in low- and middle-income countries.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.